IMPACT OF STABLE DISEASE OR BETTER RESPONSES TO LENALIDOMIDE ON SURVIVAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: MCL-001 (EMERGE) AND MCL-002 (SPRINT) STUDIES
Author
Fu, T.
Ramchandren, R.
Witzig, T. E.
Zhang, L.
Besisik, Sevgi
Trneny, M.
Bravo, M. L. Casadebaig
Barnett, E.
Biyukov, T.
Goy, A.
Arcaini, L.
Williams, M. E.
Lamy, T.
Drach, J.
Metadata
Show full item recordCollections
- Bildiri [64839]